<DOC>
	<DOCNO>NCT02516709</DOCNO>
	<brief_summary>Ongoing follow subject implant Linear Source String prostate cancer .</brief_summary>
	<brief_title>Linear Source Registry Prostate Cancer</brief_title>
	<detailed_description>This registry conduct provide long term analysis use linear Civastring source prostate cancer . Prospective data collection record demonstrate biochemical response rate . Long term side effect adverse event monitor .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Age &gt; 18 year old Plans remain care enrol physician 5 year &gt; 5 year life expectancy Signed informed consent Enrolled within 6 week implant within 365 day prior implant Not willing able comply protocol visit schedule</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>